1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina C.; Bajaj, Anshika; Archer, Jacob F.; Reeves, Rebecca S.; Ngo, Lisa Y.; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fu... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 390 Emerging safety and activity data from GEN-009–101: A phase 1/2a trial of GEN-009, a neoantigen vaccine in combination with PD-1 check-point inhibitors (CPI) in advanced solid tumors. (9th November 2020) Authors: Gillison, Maura; Cohen, Roger; Twardowski, Przemyslaw; Sukari, Ammar; Johnson, Melissa; Lackner, Rudy; Davis, Thomas; DeCillis, Arthur; Hernandez, Richard; Price, Jessica; Mancini, Kevin; Shainheit, Mara; Flechtner, Jessica; Awad, Mark Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 390 Emerging safety and activity data from GEN-009–101: A phase 1/2a trial of GEN-009, a neoantigen vaccine in combination with PD-1 check-point inhibitors (CPI) in advanced solid tumors. (9th November 2020) Authors: Gillison, Maura; Cohen, Roger; Twardowski, Przemyslaw; Sukari, Ammar; Johnson, Melissa; Lackner, Rudy; Davis, Thomas; DeCillis, Arthur; Hernandez, Richard; Price, Jessica; Mancini, Kevin; Shainheit, Mara; Flechtner, Jessica; Awad, Mark Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 407 Preliminary safety, pharmacokinetics/pharmacodynamics, and antitumor activity of XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in patients with advanced solid tumors. (10th December 2020) Authors: Shum, Elaine; Daud, Adil; Reilley, Matthew; Najjar, Yana; Thompson, John; Baranda, Joaquina; Donald Harvey, R; Leidner, Rom; Shields, Anthony; Cohen, Ezra; Cohen, Roger; Mita, Alain; Pant, Shubham; Stein, Mark; Chmielowski, Bartosz; Hu-Lieskovan, Siwen; Fleener, Catherine; Ding, Ying; Chollate, S... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 407 Preliminary safety, pharmacokinetics/pharmacodynamics, and antitumor activity of XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in patients with advanced solid tumors. (9th November 2020) Authors: Shum, Elaine; Daud, Adil; Reilley, Matthew; Najjar, Yana; Thompson, John; Baranda, Joaquina; Donald Harvey, R; Leidner, Rom; Shields, Anthony; Cohen, Ezra; Cohen, Roger; Mita, Alain; Pant, Shubham; Stein, Mark; Chmielowski, Bartosz; Hu-Lieskovan, Siwen; Fleener, Catherine; Ding, Ying; Chollate, S... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A Phase I, open-label, dose escalation study of MGA271 in combination with pembrolizumab in patients with B7-H3-expressing melanoma, squamous cell cancer of the head and neck, or squamous cell non-small cell lung cancer. Issue 2 (December 2015) Authors: Baughman, Jan; Loo, Deryk; Chen, Francine; Moore, Paul; Bonvini, Ezio; Vasselli, James; Wigginton, Jon; Cohen, Roger Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A Phase I, open-label, dose escalation study of MGA271 in combination with pembrolizumab in patients with B7-H3-expressing melanoma, squamous cell cancer of the head and neck, or squamous cell non-small cell lung cancer. (4th November 2015) Authors: Baughman, Jan; Loo, Deryk; Chen, Francine; Moore, Paul; Bonvini, Ezio; Vasselli, James; Wigginton, Jon; Cohen, Roger Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Immunotherapy with VGX-3100 (HPV16 and HPV18 plasmids) + INO-9012 (DNA encoding IL-12) in human papillomavirus (HPV) associated head and neck squamous cell carcinoma (HNSCCa): interim safety and immunogenicity results. Issue 2 (December 2015) Authors: Aggarwal, Charu; Cohen, Roger; Morrow, Matthew; Bauml, Joshua; Weinstein, Gregory; Boyer, Jean; Shen, Xuefei; Yan, Jian; Goldenberg, Jessica; Nashit, Drishty; Oyola, Sandra; Lee, Jessica; Humeau, Laurent; Weiner, David; Yang, Zane; Bagarazzi, Mark; Weiner, David Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗